Clinical Trials on Chronic Stable Plaque Psoriasis in Australia
Total 118 results
-
UCB Biopharma SRLCompletedPsoriatic Arthritis | Moderate to Severe Chronic Plaque Psoriasis | Chronic Plaque PsoriasisUnited States, Australia, Canada, Germany, Hungary, Korea, Republic of, Poland, Russian Federation, United Kingdom
-
UCB Biopharma SRLCompletedPsoriatic Arthritis | Moderate to Severe Chronic Plaque Psoriasis | Chronic Plaque PsoriasisUnited States, Australia, Belgium, Canada, Germany, Hungary, Italy, Japan, Poland, Russian Federation, United Kingdom
-
UCB Biopharma SRLCompletedModerate to Severe Chronic Plaque Psoriasis | Chronic Plaque PsoriasisUnited States, Australia, Belgium, Canada, France, Germany, Netherlands, Poland, Spain, Turkey, United Kingdom
-
Merck KGaA, Darmstadt, GermanyTerminated
-
UCB Biopharma SRLCompletedModerate to Severe Chronic Plaque Psoriasis | Chronic Plaque PsoriasisUnited States, Australia, Belgium, Canada, Germany, Hungary, Italy, Japan, Korea, Republic of, Poland, Russian Federation, Taiwan, United Kingdom
-
UCB Biopharma SRLParexelCompletedChronic Plaque PsoriasisUnited States, Australia, Canada, Moldova, Republic of
-
Santalis Pharmaceuticals, Inc.ClinDatrix, Inc.; Fremantle DermatologyWithdrawn
-
KoBioLabsActive, not recruitingA Study to Investigate Efficacy and Safety of KBL697 in Patients With Moderate Plaque Type PsoriasisPsoriatic PlaqueUnited States, Australia
-
UCB Biopharma SRLCompletedModerate to Severe Plaque Psoriasis | Chronic Plaque PsoriasisUnited States, Australia, Canada, Germany, Hungary, Korea, Republic of, Poland, Russian Federation, Taiwan
-
Zai Lab (Hong Kong), Ltd.Zai Lab (US) LLCNot yet recruiting
-
UCB Biopharma SRLCompletedChronic Plaque PsoriasisUnited States, Australia, Canada, Moldova, Republic of
-
Sun Pharmaceutical Industries LimitedActive, not recruitingChronic Plaque Psoriasis | Moderate to Severe Nail PsoriasisUnited States, Australia
-
Azora Therapeutics Australia Pty LtdActive, not recruitingPlaque Psoriasis | Nail PsoriasisAustralia
-
PfizerCompletedPlaque-type PsoriasisAustralia
-
TetraLogic PharmaceuticalsCompleted
-
Jiangsu HengRui Medicine Co., Ltd.CompletedModerate-to-severe Chronic Plaque PsoriasisUnited States, Australia, China
-
AbbVieActive, not recruitingChronic Plaque PsoriasisArgentina, Australia, Austria, Canada, Colombia, Czechia, France, Germany, Hungary, Ireland, Italy, Japan, Mexico, Netherlands, Poland, Romania, Saudi Arabia, Spain, Switzerland, United Arab Emirates, United Kingdom
-
Astellas Pharma IncBiogenCompletedChronic Plaque PsoriasisUnited States, Austria, Germany, Belgium, Canada
-
AbbVieCompletedChronic Plaque PsoriasisUnited States, Austria, Canada, Czechia, Denmark, France, Germany, Greece, Ireland, Netherlands, Puerto Rico, Spain, Sweden, United Kingdom
-
Medical University of ViennaCompletedPlaque PsoriasisAustria
-
Novartis PharmaceuticalsCompletedChronic Plaque Type PsoriasisGermany, United States, Belgium, Korea, Republic of, Spain, Taiwan, Australia, Austria, Italy, Estonia, Israel, Bulgaria, Netherlands, France, Switzerland, Portugal, Slovakia, Norway, United Kingdom, Hungary, Turkey, Canada, Denmark, ...
-
BiogenCompletedChronic Plaque PsoriasisUnited States, Germany, France, Canada, Austria, Denmark, Netherlands, Switzerland, United Kingdom
-
Almirall, S.A.Recruiting
-
Novartis PharmaceuticalsCompletedChronic Plaque PsoriasisGermany, United States, Colombia, Italy, Spain, Belgium, Egypt, Hungary, Australia, Singapore, France, Sweden, Guatemala, Philippines, Korea, Republic of, United Kingdom, Argentina, Poland, Romania, Canada, Iceland, India, Finland
-
AbbottCompletedChronic Plaque PsoriasisBelgium, Denmark, France, Germany, Spain, Sweden, Switzerland, Finland, Turkey, Italy, Czech Republic, Austria, Netherlands, United Kingdom, Greece
-
Almirall, S.A.Harrison Clinical Research; Almirall Hermal GmbHCompletedPlaque PsoriasisAustria, Germany, Netherlands, Poland
-
Maruho Europe LimitedMaruho Co., Ltd.CompletedPlaque PsoriasisGermany, Austria, Bulgaria, Hungary, Lithuania, Poland
-
Novartis PharmaceuticalsCompletedModerate to Severe Chronic Plaque-Type PsoriasisUnited States, Germany, Japan, Bulgaria, Czechia, Singapore, Switzerland, United Kingdom, Italy, France, Vietnam, Poland, Slovakia, Austria, Canada
-
Almirall, S.A.Active, not recruitingPlaque PsoriasisGermany, Austria, Italy, Netherlands
-
Arcutis Biotherapeutics, Inc.CompletedPlaque PsoriasisUnited States, Australia, Bulgaria, Canada
-
ActelionCompleted
-
AbbVieCompletedPlaque PsoriasisUnited States, Australia, Germany, Israel, Italy, Spain, Taiwan, United Kingdom
-
Bausch Health Americas, Inc.TerminatedPlaque PsoriasisUnited States, Belgium, Italy, Hungary, Poland, Australia, France, Greece, Russian Federation, Latvia, Canada
-
Coherus Biosciences, Inc.ShireCompletedPlaque PsoriasisUnited States, Israel, Australia, Germany, South Africa, Poland, Canada
-
Eli Lilly and CompanyCompletedA Study of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque Psoriasis (IXORA-S)Plaque PsoriasisGermany, Spain, Belgium, France, Hungary, Austria, Canada, Italy, Netherlands, Poland, Sweden, Switzerland, United Kingdom
-
LEO PharmaTerminatedPsoriasis | Plaque Psoriasis | Psoriasis VulgarisBelgium, Germany, Italy, Spain, Denmark, Austria, France, Greece, Switzerland, United Kingdom, Netherlands, Sweden
-
PfizerCompletedPsoriasis | Plaque PsoriasisSpain, Taiwan, Germany, Korea, Republic of, Belgium, Greece, Hungary, Argentina, Austria, Czech Republic, Italy, Mexico, Thailand
-
Bristol-Myers SquibbRecruitingPlaque PsoriasisAustralia, Mexico, Canada, United Kingdom, France, Argentina, Japan, Poland, Spain, Korea, Republic of, Brazil, Germany, Romania
-
AmgenCompletedPlaque PsoriasisSpain, United States, Canada, Germany, Denmark, France, Italy, Switzerland, Austria
-
UCB Biopharma S.P.R.L.CompletedPsoriasis | Plaque PsoriasisUnited States, Austria, Canada, Poland
-
Bausch Health Americas, Inc.TerminatedModerate to Severe Plaque PsoriasisUnited States, Austria, France, Poland, Australia, Czechia, Canada, Hungary, Portugal, Spain, Netherlands
-
Novartis PharmaceuticalsCompletedModerate and Severe Plaque PsoriasisUnited States, Argentina, Germany, Belgium, Italy, United Kingdom, Turkey, Guatemala, Australia
-
Eli Lilly and CompanyCompletedPlaque PsoriasisArgentina, Puerto Rico, United States, Australia, Taiwan, Japan, Hungary, Korea, Republic of, Mexico, Germany, Poland, Romania, Czechia, Canada
-
Janssen Research & Development, LLCRecruitingPlaque PsoriasisUnited States, Korea, Republic of, Taiwan, Germany, Poland, Brazil, Spain, Hungary, Australia, Canada, Romania
-
Janssen Research & Development, LLCActive, not recruitingPlaque PsoriasisGermany, United States, Hungary, Italy, Turkey, Korea, Republic of, United Kingdom, China, Taiwan, Poland, Canada, France, Australia, Spain, Argentina, Japan
-
Janssen Research & Development, LLCRecruitingPlaque PsoriasisKorea, Republic of, United Kingdom, United States, Poland, Germany, Brazil, Spain, Taiwan, Hungary, Japan, Canada, Argentina, Australia
-
Novartis PharmaceuticalsCompletedPlaque-type PsoriasisUnited States, Austria, Germany, France, Japan, Canada, Slovakia, India
-
AbbVie (prior sponsor, Abbott)CompletedModerate to Severe Plaque PsoriasisUnited States, Austria, Belgium, Canada, Denmark, Finland, France, Germany, Greece, Italy, Spain, Sweden, Switzerland, United Kingdom
-
Novartis PharmaceuticalsCompletedPlaque PsoriasisGermany, Belgium, Spain, Croatia, Czechia, Greece, Hungary, Russian Federation, Netherlands, Austria, France, Switzerland, Israel, United Kingdom, Italy, Lithuania, Sweden, Bulgaria, Denmark, Finland, Portugal, Slovakia, Poland, Latvia
-
Novartis PharmaceuticalsCompletedModerate to Severe Plaque-type PsoriasisGermany, United States, Belgium, Colombia, Spain, Estonia, Hungary, Japan, Lithuania, Taiwan, Australia, Korea, Republic of, Canada, Singapore, Italy, Israel, Sweden, Guatemala, United Kingdom, Argentina, France, Poland, Latvia, Iceland, Finla... and more